Phenylacetylglutamine increases the susceptibility of ventricular arrhythmias in heart failure mice by exacerbated activation of the TLR4/AKT/mTOR signaling pathway
- Resource Type
- Article
- Source
- In
International Immunopharmacology March 2023 116 - Subject
- Language
- ISSN
- 1567-5769